Patient support for those prescribed Increlex.

Once the doctor has prescribed Increlex® (mecasermin [rDNA origin] injection), the Patient Access Specialists at IPSEN CAREScan provide applicable patient coverage information, as appropriate, between the parent, caregiver, doctor’s office, insurance company, and specialty pharmacy. By serving as a central point of contact, IPSEN CARES can help patients get started on treatment and provide support throughout the process.

Step 1
Enroll

Patients must enroll in IPSEN CARES through the doctor's office to verify benefits.

Our Patient Access Specialists will check each patient’s pharmacy and medical benefits to determine if the drug is covered for the indication the treating physician has specified. If there are any restrictions, IPSEN CARES will provide the information required by the insurance company that the doctor may need to complete. A summary of all the information collected will be sent back to the doctor’s office in a single document, called Benefit Verification Results. Benefit verifications are usually turned around within 4 business hours upon receipt of the completed enrollment form and patient authorization.

Health care providers (HCPs) can help parents/caregivers enroll patients in three ways:

  1. Through our online provider portal
  2. By printing a downloadable PDF to be filled out and faxed
  3. By calling the Patient Access Specialists at IPSEN CARESat (866) 435-5677

Parents and Health Care Providers can also call IPSEN CARES at (866) 435-5677

Step 2
Authorize

Parents/caregivers are required to sign the Increlex Patient Authorization form every 12 months to give the Patient Access Specialists at IPSEN CARES permission to access the patient’s personal health information in order to help with treatment. The form can be signed and submitted online, or by downloadable PDF, which must be printed, filled out, signed, and faxed.

Parents/Caregivers, Sign and Submit
Online Patient Authorization Form
Or Download and Print
Patient Authorization Form
Step 3
Help with Copays?

Check for copay coverage. Considering that some patients need financial assistance, our copay assistance programs may help eligible* patients with their treatment.

The Increlex Copay Program for eligible, commercially insured patients is available by enrolling in IPSEN CARES. Here is the key information:

  • Patients pay no more than $100 per prescription for Increlex
  • Copay assistance may be provided with up to a maximum annual benefit of $12,000 for the program year
  • For patients who have government insurance (eg, Medicare, Medicaid, TRICARE) IPSEN CARES may be able to offer the contact information for independent nonprofit foundations that may be able to offer financial assistance
Parents/Caregivers, Download and Print
Copay Flashcard

Below Are More Ways We Can Provide Assistance

Injection Training

Injection training is provided for doctor’s offices and parents/caregivers who would like to learn how to inject Increlex. Requests to have a nurse visit the doctor’s office or patient’s home can be coordinated through IPSEN CARES.

Free Medication

Uninsured patients may be eligible for free medication through our Patient Assistance Program. To qualify, patients must be: 1) uninsured, 2) US residents, and 3) meet income criteria. Parents/caregivers may enroll their child through IPSEN CARES. If eligible, they will receive free medication from Ipsen.

Or Parents/Caregivers, Download and Print
Patient Assistance Program Form
Back to top
*Patient Eligibility & Terms and Conditions: Patients who are eligible to participate (i.e. prescriptions or coverage could be paid in part or in full) in any state or federally funded programs, including, but not limited to, Medicare or Medicaid, VA, DOD, or TRICARE (collectively, “Government Programs”) are not eligible for copay assistance through IPSEN CARES™. Patients residing in Massachusetts, Minnesota, Michigan, or Rhode Island can only receive assistance with the cost of Ipsen products but not the cost of related medical services (injection). Patients receiving free starter therapy through the IPSEN CARES program are not eligible for the copay assistance program while they are waiting for insurance prescription coverage to begin. Patients receiving assistance through another assistance program or foundation, free trial, or other similar offer or program, also are not eligible for the copay assistance program during current enrollment year.For patients with commercial insurance that are not considered to be cash-pay patients, the maximum copay benefit amount per prescription is an amount equal to the difference between the annual maximum copay benefit of $12,000 and the total amount of co-pay benefit provided to the patient in the Increlex® Copay Program for the 2016 calendar year.  For cash-pay patients, the maximum copay benefit amount per prescription is $1,000.00, subject to the annual maximum of $12,000 in total.  “Cash-pay” patients are defined for purposes of this program as patients without insurance coverage or who have commercial insurance that does not cover Increlex®.  Medicare Part D enrollees who are in the prescription drug coverage gap (“donut hole”) are not considered cash-pay patients, and are not eligible for the copay benefit. Patient pays the first $100 and any amount greater than the maximum copay savings amount per prescription.   Patient or guardian is responsible for reporting receipt of copay savings benefit to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled through the program, as may be required.  Additionally, patients may not submit any benefit provided by this program for reimbursement through Flexible Spending Account, Health Savings Account, or Health Reimbursement Account.  Ipsen reserves the right to rescind, revoke, or amend these offers without notice at any time. Ipsen and/or TrialCard, Incorporated are not responsible for any transactions processed under this program where Medicaid, Medicare, or Medigap payment in part or full has been applied. Cash-paying patients are eligible to participate. Data related to your participation may be collected, analyzed, and shared with Ipsen, for market research and other purposes related to assessing the program. Data shared with Ipsen will be de-identified, meaning it will not identify you. Void outside of the United States and its territories or where prohibited by law, taxed, or restricted.  This program is not health insurance. No other purchase is necessary. Offer expires December 31, 2017, however, patients residing in Massachusetts are only eligible to receive assistance through June 30, 2017.

Indication and Important Safety Information

SHOW MORE
Who is Increlex® for?

INCRELEX is used to treat children who are very short for their age because their bodies do not make enough IGF-1. This condition is called severe primary IGF-1 deficiency. INCRELEX should not be used instead of growth hormone.

Who should not use Increlex?

Your child should not take INCRELEX if your child: has finished growing (the growth plates at the end of the bones are closed); has cancer; has other causes of growth failure; OR is allergic to mecasermin or any of the inactive ingredients in INCRELEX. INCRELEX has not been studied in children under 2 years of age and should never be used in newborns. Your child should never receive INCRELEX through a vein.

Before your child takes Increlex, you should tell your child's doctor about:

All of your child's health conditions, including: diabetes, kidney problems, liver problems, allergies, scoliosis (curved spine), pregnancy, or breast-feeding.

All the medicines (prescription and nonprescription), vitamins, and herbal supplements your child takes, especially insulin or other anti-diabetes medicines, which may require dose adjustment of these medicines.

What are possible side effects of Increlex (some of which can be serious)?

Low blood sugar (hypoglycemia). Only give your child INCRELEX right before or right after (20 minutes on either side of) a snack or meal to reduce the chances of hypoglycemia. Signs include dizziness, tiredness, restlessness, hunger, irritability, trouble concentrating, sweating, nausea, and fast or irregular heartbeat. Do not give your child INCRELEX if your child is sick or cannot eat.

Severe hypoglycemia may cause unconsciousness, seizures, or death. People taking INCRELEX should avoid participating in high risk activities (such as driving) within 2 to 3 hours after an INCRELEX injection.

Increased pressure in the brain (intracranial hypertension). INCRELEX, like growth hormone, can sometimes cause a temporary increase in pressure within the brain. Symptoms include persistent headache, blurred vision, and nausea with vomiting.

Allergic reactions. Your child may have a mild or serious allergic reaction with Increlex. Call your child's doctor right away if your child gets a rash or hives. Hives, also known as urticaria, appear as a raised, itchy skin reaction. Hives appear pale in the middle with a red rim around them. Hives generally appear minutes to hours after the injection and may sometimes occur at numerous places on the skin. Get medical help immediately if your child has trouble breathing or goes into shock, with symptoms like dizziness, pale, clammy skin, and/or passing out.

Enlarged tonsils. Signs include: snoring, difficulty breathing or swallowing, sleep apnea (a condition where breathing stops briefly during sleep), or fluid in the middle ear.

A bone problem called slipped capital femoral epiphysis. This happens when the top of the upper leg (femur) slips apart from the rest of the bone. Seek immediate medical attention if your child develops a limp or has hip or knee pain.

Worsened scoliosis (caused by rapid growth).

Injection site reactions including: swelling, loss of fat, increase of fat, pain, redness, or bruising. This can be avoided by changing/rotating the injection site at each injection.

Your child's doctor is your primary source of information about treatment. For more information, please talk to your doctor and download and review the full Patient Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

See Patient Information for Increlex

See Full Prescribing Information for Increlex

Need immediate assistance?Call (866) 435-5677.

Our Patient Access Specialists are available Monday-Friday, from 8:00 AM to 8:00 PM ET (5:00 AM to 5:00 PM PT).

Leaving Website

NOTE: You are about to leave an Ipsen Biopharmaceuticals, Inc. website. This link is provided to you as a service to our website visitors. It will take you to another site maintained by a third party who is solely responsible for its content.

Ipsen Biopharmaceuticals, Inc., does not control or endorse this site. Ipsen is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit. Click “OK” to proceed or “CANCEL” to return to ipsencares.com.

This document is not currently available. Please check back again or contact IPSEN CARES at 1-866-435-5677 (8 AM – 8 PM ET, Monday through Friday).